Your browser is no longer supported. Please, upgrade your browser.
Settings
ASRT Assertio Holdings, Inc. daily Stock Chart
ASRT [NASD]
Assertio Holdings, Inc.
Index- P/E- EPS (ttm)-1.97 Insider Own3.40% Shs Outstand70.94M Perf Week2.60%
Market Cap89.42M Forward P/E5.58 EPS next Y0.15 Insider Trans-0.43% Shs Float61.33M Perf Month-9.01%
Income-161.70M PEG- EPS next Q-0.03 Inst Own64.30% Short Float2.81% Perf Quarter-6.97%
Sales192.50M P/S0.46 EPS this Y-634.30% Inst Trans23.37% Short Ratio1.19 Perf Half Y-27.82%
Book/sh1.18 P/B0.71 EPS next Y36.36% ROA-27.90% Target Price- Perf Year-74.39%
Cash/sh- P/C- EPS next 5Y25.00% ROE-110.00% 52W Range0.55 - 3.55 Perf YTD-33.02%
Dividend- P/FCF2.44 EPS past 5Y-28.50% ROI-39.80% 52W High-76.41% Beta2.15
Dividend %- Quick Ratio1.50 Sales past 5Y-10.10% Gross Margin95.70% 52W Low52.24% ATR0.06
Employees125 Current Ratio1.50 Sales Q/Q-63.90% Oper. Margin-55.90% RSI (14)49.33 Volatility4.87% 7.18%
OptionableYes Debt/Eq0.69 EPS Q/Q360.70% Profit Margin-84.00% Rel Volume0.48 Prev Close0.81
ShortableYes LT Debt/Eq0.00 EarningsMay 11 BMO Payout- Avg Volume1.44M Price0.84
Recom2.00 SMA20-1.32% SMA50-4.24% SMA200-13.09% Volume685,403 Change2.80%
Nov-30-18Downgrade Mizuho Buy → Neutral
Jul-08-20 07:00AM  
Jun-30-20 11:50PM  
Jun-24-20 06:27PM  
May-22-20 07:24AM  
May-21-20 06:30AM  
May-20-20 06:20PM  
08:48AM  
May-17-20 08:09AM  
May-11-20 10:35AM  
08:17AM  
08:00AM  
May-08-20 10:41PM  
10:10PM  
07:02PM  
May-06-20 12:30PM  
Apr-30-20 12:00PM  
Apr-20-20 05:08PM  
Apr-08-20 04:05PM  
Apr-02-20 06:24AM  
Mar-17-20 11:41AM  
10:15AM  
Mar-16-20 06:45PM  
Mar-11-20 01:01AM  
Mar-09-20 05:55PM  
04:02PM  
02:30AM  
Mar-08-20 04:14PM  
Mar-02-20 05:30PM  
Feb-26-20 12:30PM  
Feb-24-20 10:33AM  
Feb-19-20 08:00AM  
Feb-17-20 06:00AM  
Feb-14-20 08:23AM  
Feb-13-20 04:05PM  
Feb-07-20 07:32AM  
Feb-06-20 04:01PM  
Feb-04-20 05:45PM  
Jan-29-20 05:45PM  
Jan-22-20 11:30AM  
Jan-15-20 05:45PM  
Jan-13-20 11:40AM  
07:50AM  
Jan-09-20 05:45PM  
Jan-08-20 10:18AM  
Jan-07-20 09:51AM  
09:17AM  
Dec-27-19 11:40AM  
Dec-23-19 12:00PM  
Dec-19-19 06:40AM  
Dec-13-19 03:07PM  
08:39AM  
Dec-12-19 07:50AM  
Dec-10-19 11:40AM  
Nov-26-19 02:29PM  
Nov-13-19 12:58PM  
Nov-07-19 11:26AM  
Nov-06-19 07:45PM  
04:05PM  
Nov-04-19 06:05AM  
Oct-30-19 06:35PM  
10:34AM  
Oct-23-19 09:05AM  
Oct-22-19 07:51AM  
Oct-21-19 09:05AM  
Oct-13-19 04:33PM  
Oct-05-19 09:54AM  
Sep-30-19 12:35PM  
Sep-26-19 08:00AM  
Sep-24-19 05:38PM  
Sep-20-19 09:40AM  
Sep-09-19 09:50AM  
Sep-05-19 11:05AM  
Sep-04-19 09:30AM  
Aug-20-19 08:00AM  
07:59AM  
Aug-19-19 09:30AM  
Aug-12-19 09:15PM  
Aug-09-19 09:28AM  
Aug-08-19 11:24PM  
Aug-07-19 07:35PM  
04:02PM  
Aug-06-19 03:22PM  
Jul-31-19 10:36AM  
Jul-26-19 09:30AM  
Jul-17-19 04:05PM  
Jul-01-19 08:39AM  
Jun-23-19 08:53PM  
Jun-22-19 10:37AM  
Jun-13-19 09:50AM  
May-20-19 10:28AM  
May-14-19 09:30AM  
May-09-19 11:24AM  
May-08-19 05:25PM  
04:17PM  
04:02PM  
May-06-19 11:54AM  
May-01-19 10:33AM  
Apr-24-19 04:46PM  
Apr-23-19 08:22AM  
Apr-16-19 07:17PM  
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in neurology, orphan, and specialty areas in the United States. The company offers Gralise (gabapentin), a once daily product for the management of postherpetic neuralgia; CAMBIA (diclofenac potassium for oral solution), a non-steroidal anti-inflammatory drug for the acute treatment of migraine attacks; and Zipsor (diclofenac potassium liquid filled capsules), a non-steroidal anti-inflammatory drug for treating mild to moderate acute pain. It also provides NUCYNTA ER (tapentadol extended release tablet), a product for the management of pain severe enough to require daily, around-the-clock, and long term opioid treatment, including neuropathic pain related to diabetic peripheral neuropathy in adults; and NUCYNTA IR (tapentadol), a product for the management of moderate to severe acute pain in adults. In addition, the company offers long-acting cosyntropin, an alcohol-free formulation of synthetic adrenocorticotropic hormone. Assertio Therapeutics, Inc. has a collaboration and license agreement with Ironwood Pharmaceuticals, Inc. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was founded in 1995 and is headquartered in Lake Forest, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DAWES KAREN ADirectorMay 08Sale0.7915,83412,53184,589May 11 08:23 PM
Bukofzer StanSVP, Chf Scitfc & Tech OfficerApr 02Option Exercise0.0025,370070,349Apr 03 06:50 PM
Galeota James JRDirectorMar 30Option Exercise0.0012,492012,492Mar 31 07:32 PM
Mason Heather LDirectorFeb 18Option Exercise0.0014,394014,394Feb 19 05:00 PM
Peisert Daniel A.SVP and CFOFeb 12Option Exercise0.0027,5880112,753Feb 12 06:41 PM
Bukofzer StanSVP, Chf Scitfc & Tech OfficerFeb 12Option Exercise0.0027,588054,524Feb 12 06:40 PM
HIGGINS ARTHUR JDirector, President and CEOFeb 12Option Exercise0.0097,4120275,747Feb 12 06:41 PM
HIGGINS ARTHUR JDirector, President and CEOFeb 06Option Exercise0.0062,3990199,925Feb 06 05:49 PM
Peisert Daniel A.SVP and CFOFeb 06Option Exercise0.006,700087,483Feb 06 05:49 PM
HIGGINS ARTHUR JDirector, President and CEODec 01Option Exercise0.0034,8600147,739Dec 02 05:20 PM
Peisert Daniel A.SVP and CFODec 01Option Exercise0.008,359083,232Dec 02 05:20 PM
HIGGINS ARTHUR JDirector, President and CEONov 12Buy0.7325,00018,250112,879Nov 12 04:36 PM
Peisert Daniel A.SVP and CFONov 11Buy0.7310,0007,25974,873Nov 12 04:36 PM
STAPLE PETER DDirectorNov 11Buy0.7113,9009,91113,900Nov 12 04:36 PM